A detailed history of Pittenger & Anderson Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Pittenger & Anderson Inc holds 53,377 shares of AZN stock, worth $3.44 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
53,377
Previous 46,787 14.09%
Holding current value
$3.44 Million
Previous $3.65 Million 14.01%
% of portfolio
0.17%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$76.67 - $87.62 $505,255 - $577,415
6,590 Added 14.09%
53,377 $4.16 Million
Q2 2024

Aug 09, 2024

BUY
$66.81 - $80.83 $857,974 - $1.04 Million
12,842 Added 37.83%
46,787 $3.65 Million
Q1 2024

May 02, 2024

BUY
$61.03 - $69.57 $2.06 Million - $2.35 Million
33,790 Added 21800.0%
33,945 $2.3 Million
Q4 2023

Feb 02, 2024

BUY
$61.89 - $69.28 $9,592 - $10,738
155 New
155 $10,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Pittenger & Anderson Inc Portfolio

Follow Pittenger & Anderson Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pittenger & Anderson Inc with notifications on news.